Accurate human papillomavirus genotyping by 454 pyrosequencing

Area of Science:

• Virology
• Genetics
• Molecular Biology

Background:

• Accurate human papillomavirus (HPV) typing is crucial for HPV vaccine evaluation, cervical cancer screening, and epidemiological studies.
• Existing HPV typing methods may have limitations in sensitivity and breadth of coverage for certain HPV types.

Purpose of the Study:

• To develop and clinically validate a novel HPV typing method utilizing 454 next-generation sequencing (NGS) of HPV L1 amplicons.
• To enhance sensitivity for underrepresented HPV types using a modified PGMY primer set.

Main Methods:

• The study employed 454 pyrosequencing of HPV L1 amplicons generated with a modified PGMY primer set.
• The method's performance was assessed using WHO LabNet EQA sample panels, mixtures of HPV16/18 cell lines, and clinical cervical specimens.

Main Results:

• The NGS method demonstrated high sensitivity (50 genome equivalents) and correctly identified all high-risk HPV types in single and multiple infections.
• It accurately quantified HPV proportions in mixed infections and resolved discordant results from other typing assays.
• The method showed high precision, specificity, and the ability to detect a broad range of HPV types.

Conclusions:

• A novel, sensitive, specific, and quantitative HPV typing method based on 454 NGS was successfully established.
• This method is effective for analyzing single and multiple HPV infections, including those with discordant results from other assays.
• The developed NGS approach holds potential for identifying known and potentially novel HPV types.